Tag: SPIRARE II
Enrolment in SPIRARE II pivotal trial of embolectomy system for pulmonary...
Jupiter Endovascular today announced completion of patient enrolment in the SPIRARE II pivotal trial evaluating the Vertex pulmonary embolectomy system in patients with acute,...
Jupiter Endovascular announces US FDA approval for SPIRARE II pivotal trial
Jupiter Endovascular has announced that the US Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for the SPIRARE II US pivotal study. The pivotal trial will...